Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.
Identifieur interne : 000A67 ( Main/Exploration ); précédent : 000A66; suivant : 000A68Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.
Auteurs : Romain Courcelle [Belgique] ; Stéphane Gaudry [France] ; Nicolas Serck [Belgique] ; Gauthier Blonz [France] ; Jean-Baptiste Lascarrou [France] ; David Grimaldi [Belgique]Source :
- Critical care (London, England) [ 1466-609X ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Curarisants (usage thérapeutique), Femelle (MeSH), Humains (MeSH), Infections à coronavirus (complications), Infections à coronavirus (traitement médicamenteux), Mâle (MeSH), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (traitement médicamenteux), Résultat thérapeutique (MeSH), Sujet âgé (MeSH), Syndrome de détresse respiratoire de l'adulte (traitement médicamenteux), Syndrome de détresse respiratoire de l'adulte (virologie), Études prospectives (MeSH).
- MESH :
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale, Syndrome de détresse respiratoire de l'adulte.
- usage thérapeutique : Curarisants, Infections à coronavirus, Pneumopathie virale.
- virologie : Syndrome de détresse respiratoire de l'adulte.
- Adulte d'âge moyen, Femelle, Humains, Mâle, Pandémies, Résultat thérapeutique, Sujet âgé, Études prospectives.
English descriptors
- KwdEn :
- Aged (MeSH), Coronavirus Infections (complications), Coronavirus Infections (drug therapy), Female (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Neuromuscular Blocking Agents (therapeutic use), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (drug therapy), Prospective Studies (MeSH), Respiratory Distress Syndrome, Adult (drug therapy), Respiratory Distress Syndrome, Adult (virology), Treatment Outcome (MeSH).
- MESH :
- chemical , therapeutic use : Neuromuscular Blocking Agents.
- complications : Coronavirus Infections, Pneumonia, Viral.
- drug therapy : Coronavirus Infections, Pneumonia, Viral, Respiratory Distress Syndrome, Adult.
- virology : Respiratory Distress Syndrome, Adult.
- Aged, Female, Humans, Male, Middle Aged, Pandemics, Prospective Studies, Treatment Outcome.
DOI: 10.1186/s13054-020-03164-2
PubMed: 32684169
PubMed Central: PMC7369441
Affiliations:
- Belgique, France
- Pays de la Loire, Région de Bruxelles-Capitale, Île-de-France
- Bobigny, Bruxelles, La Roche-sur-Yon, Nantes
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.</title><author><name sortKey="Courcelle, Romain" sort="Courcelle, Romain" uniqKey="Courcelle R" first="Romain" last="Courcelle">Romain Courcelle</name><affiliation wicri:level="1"><nlm:affiliation>Unité de soins intensifs, Centres Hospitaliers de Jolimont, La Louvière, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Unité de soins intensifs, Centres Hospitaliers de Jolimont, La Louvière</wicri:regionArea><wicri:noRegion>La Louvière</wicri:noRegion></affiliation></author><author><name sortKey="Gaudry, Stephane" sort="Gaudry, Stephane" uniqKey="Gaudry S" first="Stéphane" last="Gaudry">Stéphane Gaudry</name><affiliation wicri:level="3"><nlm:affiliation>Réanimation médico-chirurgicale CHU Avicenne, Université Sorbonne Paris Nord, Bobigny, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Réanimation médico-chirurgicale CHU Avicenne, Université Sorbonne Paris Nord, Bobigny</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Bobigny</settlement></placeName></affiliation></author><author><name sortKey="Serck, Nicolas" sort="Serck, Nicolas" uniqKey="Serck N" first="Nicolas" last="Serck">Nicolas Serck</name><affiliation wicri:level="1"><nlm:affiliation>Unité de soins intensifs, Clinique Saint Pierre, Ottignies, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Unité de soins intensifs, Clinique Saint Pierre, Ottignies</wicri:regionArea><wicri:noRegion>Ottignies</wicri:noRegion></affiliation></author><author><name sortKey="Blonz, Gauthier" sort="Blonz, Gauthier" uniqKey="Blonz G" first="Gauthier" last="Blonz">Gauthier Blonz</name><affiliation wicri:level="3"><nlm:affiliation>Medecine Intensive Reanimation, District Hospital Center, Boulevard Stephane Moreau, 85000, La Roche Sur Yon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Medecine Intensive Reanimation, District Hospital Center, Boulevard Stephane Moreau, 85000, La Roche Sur Yon</wicri:regionArea><placeName><region type="region" nuts="2">Pays de la Loire</region><settlement type="city">La Roche-sur-Yon</settlement></placeName></affiliation></author><author><name sortKey="Lascarrou, Jean Baptiste" sort="Lascarrou, Jean Baptiste" uniqKey="Lascarrou J" first="Jean-Baptiste" last="Lascarrou">Jean-Baptiste Lascarrou</name><affiliation wicri:level="3"><nlm:affiliation>Medecine Intensive Reanimation, CHU Nantes, 30 Boulevard Jean Monnet, 44093, Nantes Cedex 9, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Medecine Intensive Reanimation, CHU Nantes, 30 Boulevard Jean Monnet, 44093, Nantes Cedex 9</wicri:regionArea><placeName><region type="region" nuts="2">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Grimaldi, David" sort="Grimaldi, David" uniqKey="Grimaldi D" first="David" last="Grimaldi">David Grimaldi</name><affiliation wicri:level="3"><nlm:affiliation>Soins Intensifs, Hôpital Erasme, ULB, Route de Lennik 808, 1070, Bruxelles, Belgium. david.grimaldi@erasme.ulb.ac.be.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Soins Intensifs, Hôpital Erasme, ULB, Route de Lennik 808, 1070, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32684169</idno><idno type="pmid">32684169</idno><idno type="doi">10.1186/s13054-020-03164-2</idno><idno type="pmc">PMC7369441</idno><idno type="wicri:Area/Main/Corpus">000904</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000904</idno><idno type="wicri:Area/Main/Curation">000904</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000904</idno><idno type="wicri:Area/Main/Exploration">000904</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.</title><author><name sortKey="Courcelle, Romain" sort="Courcelle, Romain" uniqKey="Courcelle R" first="Romain" last="Courcelle">Romain Courcelle</name><affiliation wicri:level="1"><nlm:affiliation>Unité de soins intensifs, Centres Hospitaliers de Jolimont, La Louvière, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Unité de soins intensifs, Centres Hospitaliers de Jolimont, La Louvière</wicri:regionArea><wicri:noRegion>La Louvière</wicri:noRegion></affiliation></author><author><name sortKey="Gaudry, Stephane" sort="Gaudry, Stephane" uniqKey="Gaudry S" first="Stéphane" last="Gaudry">Stéphane Gaudry</name><affiliation wicri:level="3"><nlm:affiliation>Réanimation médico-chirurgicale CHU Avicenne, Université Sorbonne Paris Nord, Bobigny, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Réanimation médico-chirurgicale CHU Avicenne, Université Sorbonne Paris Nord, Bobigny</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Bobigny</settlement></placeName></affiliation></author><author><name sortKey="Serck, Nicolas" sort="Serck, Nicolas" uniqKey="Serck N" first="Nicolas" last="Serck">Nicolas Serck</name><affiliation wicri:level="1"><nlm:affiliation>Unité de soins intensifs, Clinique Saint Pierre, Ottignies, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Unité de soins intensifs, Clinique Saint Pierre, Ottignies</wicri:regionArea><wicri:noRegion>Ottignies</wicri:noRegion></affiliation></author><author><name sortKey="Blonz, Gauthier" sort="Blonz, Gauthier" uniqKey="Blonz G" first="Gauthier" last="Blonz">Gauthier Blonz</name><affiliation wicri:level="3"><nlm:affiliation>Medecine Intensive Reanimation, District Hospital Center, Boulevard Stephane Moreau, 85000, La Roche Sur Yon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Medecine Intensive Reanimation, District Hospital Center, Boulevard Stephane Moreau, 85000, La Roche Sur Yon</wicri:regionArea><placeName><region type="region" nuts="2">Pays de la Loire</region><settlement type="city">La Roche-sur-Yon</settlement></placeName></affiliation></author><author><name sortKey="Lascarrou, Jean Baptiste" sort="Lascarrou, Jean Baptiste" uniqKey="Lascarrou J" first="Jean-Baptiste" last="Lascarrou">Jean-Baptiste Lascarrou</name><affiliation wicri:level="3"><nlm:affiliation>Medecine Intensive Reanimation, CHU Nantes, 30 Boulevard Jean Monnet, 44093, Nantes Cedex 9, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Medecine Intensive Reanimation, CHU Nantes, 30 Boulevard Jean Monnet, 44093, Nantes Cedex 9</wicri:regionArea><placeName><region type="region" nuts="2">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Grimaldi, David" sort="Grimaldi, David" uniqKey="Grimaldi D" first="David" last="Grimaldi">David Grimaldi</name><affiliation wicri:level="3"><nlm:affiliation>Soins Intensifs, Hôpital Erasme, ULB, Route de Lennik 808, 1070, Bruxelles, Belgium. david.grimaldi@erasme.ulb.ac.be.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Soins Intensifs, Hôpital Erasme, ULB, Route de Lennik 808, 1070, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author></analytic><series><title level="j">Critical care (London, England)</title><idno type="eISSN">1466-609X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (drug therapy)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Neuromuscular Blocking Agents (therapeutic use)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (drug therapy)</term><term>Prospective Studies (MeSH)</term><term>Respiratory Distress Syndrome, Adult (drug therapy)</term><term>Respiratory Distress Syndrome, Adult (virology)</term><term>Treatment Outcome (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term><term>Curarisants (usage thérapeutique)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (complications)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Mâle (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (complications)</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Résultat thérapeutique (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Syndrome de détresse respiratoire de l'adulte (traitement médicamenteux)</term><term>Syndrome de détresse respiratoire de l'adulte (virologie)</term><term>Études prospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Neuromuscular Blocking Agents</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term><term>Respiratory Distress Syndrome, Adult</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Syndrome de détresse respiratoire de l'adulte</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Curarisants</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome de détresse respiratoire de l'adulte</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Respiratory Distress Syndrome, Adult</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Prospective Studies</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Pandémies</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32684169</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>07</Month><Day>19</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.</ArticleTitle><Pagination><MedlinePgn>446</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-020-03164-2</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Courcelle</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unité de soins intensifs, Centres Hospitaliers de Jolimont, La Louvière, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaudry</LastName><ForeName>Stéphane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Réanimation médico-chirurgicale CHU Avicenne, Université Sorbonne Paris Nord, Bobigny, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serck</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Unité de soins intensifs, Clinique Saint Pierre, Ottignies, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blonz</LastName><ForeName>Gauthier</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medecine Intensive Reanimation, District Hospital Center, Boulevard Stephane Moreau, 85000, La Roche Sur Yon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lascarrou</LastName><ForeName>Jean-Baptiste</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Medecine Intensive Reanimation, CHU Nantes, 30 Boulevard Jean Monnet, 44093, Nantes Cedex 9, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grimaldi</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8428-065X</Identifier><AffiliationInfo><Affiliation>Soins Intensifs, Hôpital Erasme, ULB, Route de Lennik 808, 1070, Bruxelles, Belgium. david.grimaldi@erasme.ulb.ac.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>on behalf the COVADIS study group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009466">Neuromuscular Blocking Agents</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009466" MajorTopicYN="N">Neuromuscular Blocking Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome, Adult</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Aissaoui</LastName><ForeName>Nadia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carbutti</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'hondt</LastName><ForeName>Alain</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Higny</LastName><ForeName>Julien</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horlait</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hraiech</LastName><ForeName>Sami</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lefebvre</LastName><ForeName>Laurent</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lejeune</LastName><ForeName>Francois</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ly</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piagnerelli</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sauneuf</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soumagne</LastName><ForeName>Thibaud</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Szychowiak</LastName><ForeName>Piotr</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Textoris</LastName><ForeName>Julien</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vandenbunder</LastName><ForeName>Benoit</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vinsonneau</LastName><ForeName>Christophe</ForeName><Initials>C</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>06</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>07</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32684169</ArticleId><ArticleId IdType="doi">10.1186/s13054-020-03164-2</ArticleId><ArticleId IdType="pii">10.1186/s13054-020-03164-2</ArticleId><ArticleId IdType="pmc">PMC7369441</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Am Thorac Soc. 2020 May 20;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32432896</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2020 Apr 16;24(1):154</Citation><ArticleIdList><ArticleId IdType="pubmed">32299472</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2019 May 23;380(21):1997-2008</Citation><ArticleIdList><ArticleId IdType="pubmed">31112383</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Feb 23;315(8):788-800</Citation><ArticleIdList><ArticleId IdType="pubmed">26903337</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2010 Sep 16;363(12):1107-16</Citation><ArticleIdList><ArticleId IdType="pubmed">20843245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intensive Care. 2019 Jun 13;9(1):69</Citation><ArticleIdList><ArticleId IdType="pubmed">31197492</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Belgique</li><li>France</li></country><region><li>Pays de la Loire</li><li>Région de Bruxelles-Capitale</li><li>Île-de-France</li></region><settlement><li>Bobigny</li><li>Bruxelles</li><li>La Roche-sur-Yon</li><li>Nantes</li></settlement></list><tree><country name="Belgique"><noRegion><name sortKey="Courcelle, Romain" sort="Courcelle, Romain" uniqKey="Courcelle R" first="Romain" last="Courcelle">Romain Courcelle</name></noRegion><name sortKey="Grimaldi, David" sort="Grimaldi, David" uniqKey="Grimaldi D" first="David" last="Grimaldi">David Grimaldi</name><name sortKey="Serck, Nicolas" sort="Serck, Nicolas" uniqKey="Serck N" first="Nicolas" last="Serck">Nicolas Serck</name></country><country name="France"><region name="Île-de-France"><name sortKey="Gaudry, Stephane" sort="Gaudry, Stephane" uniqKey="Gaudry S" first="Stéphane" last="Gaudry">Stéphane Gaudry</name></region><name sortKey="Blonz, Gauthier" sort="Blonz, Gauthier" uniqKey="Blonz G" first="Gauthier" last="Blonz">Gauthier Blonz</name><name sortKey="Lascarrou, Jean Baptiste" sort="Lascarrou, Jean Baptiste" uniqKey="Lascarrou J" first="Jean-Baptiste" last="Lascarrou">Jean-Baptiste Lascarrou</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A67 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A67 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32684169
|texte= Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32684169" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |